Table 4.

Clinical outcomes

	Group A ASA	Group B ASA + Clopidogrel	P
AMI	1 (2%)	0%	0.5 (F-t)
IABP	3 (6%)	2 (4%)	0.5 (F-t)
Stroke	1 (2%)	0 (0%)	0.5 (F-t)
Renal failure	1 (2%)	1 (2%)	1.0 (F-t)
AF	12 (24%)	7 (14%)	0.15 (F-t)
MV (h)	8 ± 11	6 ± 2	0.22 (KW)
ICU stay (d)	1.8 ± 3.3 (Med 1)	1.4 ± 0.9 (Med 1)	0.77 (KW)
Mortality	1 (2%)	0 (0%)	0.5 (F-t)
MACE (death, stroke. AMI)	3 (6%)	0 (0%)	0.24 (F-t)

F-t: Fisher’s exact test; KW: Kruskal Wallis-test; ASA: Acetylsalycilic acid; AMI: Acute myocardial infarction; AF: Atrial fibrillation; MV: Mechanical ventilation; MACE: Major adverse cardiac events.